AIDA researchers have published a significant scientific advance in Nature Communications: an AI-powered “Clinician” capable of recommending personalised treatment for Helicobacter pylori (H. pylori), the leading cause of gastric cancer worldwide.
The system was developed using reinforcement learning and trained on real-world data from more than 38,000 patients in the European Hp-EuReg registry. The results are striking. AI-recommended therapies showed a 94.1% eradication success rate, compared with 88.1% for standard treatment.
This innovative approach does not replace doctors but strengthens clinical decision-making. By analysing thousands of patient profiles and treatment pathways, the AI provides evidence-based recommendations tailored to each individual. The system is currently being evaluated for integration into future clinical workflows.
This achievement marks an important step in AIDA’s mission to reduce gastric cancer burden through advanced diagnostic and therapeutic tools powered by artificial intelligence.
